Singapore markets closed

Burning Rock Biotech Limited (BNR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7978-0.0122 (-1.51%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 83.41M
Enterprise value 137.19k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.12
Price/book (mrq)0.79
Enterprise value/revenue 0.00
Enterprise value/EBITDA -0.00

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-71.57%
S&P500 52-week change 325.77%
52-week high 33.0100
52-week low 30.5720
50-day moving average 30.7675
200-day moving average 30.9971

Share statistics

Avg vol (3-month) 353.44k
Avg vol (10-day) 368.98k
Shares outstanding 5102.59M
Implied shares outstanding 6102.59M
Float 856.59M
% held by insiders 10.12%
% held by institutions 161.03%
Shares short (15 Apr 2024) 4397.91k
Short ratio (15 Apr 2024) 414.61
Short % of float (15 Apr 2024) 40.04%
Short % of shares outstanding (15 Apr 2024) 40.04%
Shares short (prior month 15 Mar 2024) 4410.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -121.63%
Operating margin (ttm)-137.36%

Management effectiveness

Return on assets (ttm)-31.84%
Return on equity (ttm)-67.85%

Income statement

Revenue (ttm)537.44M
Revenue per share (ttm)5.25
Quarterly revenue growth (yoy)-14.90%
Gross profit (ttm)N/A
EBITDA -537.87M
Net income avi to common (ttm)-653.69M
Diluted EPS (ttm)-0.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)628.5M
Total cash per share (mrq)6.13
Total debt (mrq)12.32M
Total debt/equity (mrq)1.60%
Current ratio (mrq)3.36
Book value per share (mrq)7.50

Cash flow statement

Operating cash flow (ttm)-255.78M
Levered free cash flow (ttm)-57.45M